Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Longevity Genes in Founder Populations Project
This study is currently recruiting participants.
Verified by Albert Einstein College of Medicine of Yeshiva University, June 2008
Sponsors and Collaborators: Albert Einstein College of Medicine of Yeshiva University
National Institutes of Health (NIH)
Information provided by: Albert Einstein College of Medicine of Yeshiva University
ClinicalTrials.gov Identifier: NCT00707694
  Purpose

We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of our research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.


Condition
Extreme Longevity

U.S. FDA Resources
Study Type: Observational
Study Design: Case Control, Prospective
Official Title: Searching for Longevity Genes in the Historically Unique Ashkenazi Jewish Population

Further study details as provided by Albert Einstein College of Medicine of Yeshiva University:

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Estimated Enrollment: 1500
Study Start Date: July 1998
Groups/Cohorts
Probands
Ashkenazi Jews ages 95 and older
Offspring
Ashkenazi Jewish offspring of Ashkenazi Jewish parent(s) who lived to at least the age of 95
Controls
Ashkenazi Jewish people with no family history of longevity

  Eligibility

Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Ashkenazi Jews:

Ages 95 and older, their offspring and control group with no family history of longevity.

Criteria

Inclusion Criteria:

  • Ashkenazi Jewish, age 95+,
  • Offspring of person age 95+,
  • Offspring of parents who died age 70 or younger.

Exclusion Criteria:

  • Non-Ashkenazis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00707694

Contacts
Contact: Deborah Davidson, MBA 718-430-3237 longevity@aecom.yu.edu

Locations
United States, New York
Hebrew Home Riverdale Recruiting
Riverdale, New York, United States, 10471
Contact: Charlotte Dell, LMSW     718-581-1139        
Sponsors and Collaborators
Albert Einstein College of Medicine of Yeshiva University
Investigators
Principal Investigator: Nir Barzilai, MD Albert Einstein College of Medicine of Yeshiva University
  More Information

Responsible Party: Albert Einstein College of Medicine of Yeshiva University ( Nir Barzilai, MD )
Study ID Numbers: 1998-125
Study First Received: June 27, 2008
Last Updated: June 30, 2008
ClinicalTrials.gov Identifier: NCT00707694  
Health Authority: United States: Institutional Review Board

Keywords provided by Albert Einstein College of Medicine of Yeshiva University:
95 years of age and older

ClinicalTrials.gov processed this record on January 16, 2009